[Transforaminal epidural @entity134 injection under computed tomography guidance in relieving XXXX ].

@entity1 @entity134 @entity158 @entity612
OBJECTIVES: We analyzed the efficacy of transforaminal epidural @entity134 injections under computed tomography (CT) in relieving @entity158 due to @entity612 . METHODS: Forty-two @entity1 (7 males, 35 females; mean age 67 years; range 34 to 90 years) with @entity158 due to @entity612 were prospectively monitored following transforaminal epidural @entity134 injections under computed tomography. Injections were repeated twice in two @entity1 (4.8%) and three times in one @entity1 (2.4%). The severity of @entity158 was assessed with the use of a visual analog scale (VAS) before and after injections (1st day, 1st week, 3rd week, 6th month, and the last follow-up). The mean follow-up period was 12.1 months (range 6 to 25 months). RESULTS: The median VAS score before injections was 9 (range 6 to 10). During the first six months, the median VAS scores were always significantly lower than the preinjection score (p<0.005). The mean VAS score of 23 @entity1 with a follow-up of at least a year was still significantly lower than that obtained at the end of six months (2.26 vs 2.52, p<0.005). No procedure-related complications occurred. CONCLUSION: Selective transforaminal epidural @entity134 and analgesic injection under CT guidance is a safe and reliable conservative method to relieve @entity158 due to @entity612 .
